136 related articles for article (PubMed ID: 20491651)
1. Medicinal chemistry of antiviral/anticancer prodrugs subjected to phosphate conjugation.
Kalász H; Adem A; Hasan MY; Adeghate E; Ram N; Gulyás Z; Tekes K
Mini Rev Med Chem; 2010 Aug; 10(9):822-45. PubMed ID: 20491651
[TBL] [Abstract][Full Text] [Related]
2. Strategies in the designing of prodrugs, taking into account the antiviral and anticancer compounds.
Lesniewska-Kowiel MA; Muszalska I
Eur J Med Chem; 2017 Mar; 129():53-71. PubMed ID: 28219047
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside Phosphate-Conjugates Come of Age: Catalytic Transformation, Polymerase Recognition and Antiviral Properties.
Groaz E; Herdewijn P
Curr Med Chem; 2015; 22(34):3980-90. PubMed ID: 26597062
[TBL] [Abstract][Full Text] [Related]
4. Current prodrug design for drug discovery.
Hsieh PW; Hung CF; Fang JY
Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825
[TBL] [Abstract][Full Text] [Related]
5. Prodrug applications for targeted cancer therapy.
Giang I; Boland EL; Poon GM
AAPS J; 2014 Sep; 16(5):899-913. PubMed ID: 25004822
[TBL] [Abstract][Full Text] [Related]
6. Pronucleotides: toward the in vivo delivery of antiviral and anticancer nucleotides.
Wagner CR; Iyer VV; McIntee EJ
Med Res Rev; 2000 Nov; 20(6):417-51. PubMed ID: 11058891
[TBL] [Abstract][Full Text] [Related]
7. [Modified nucleoside phosphates as precursors of antineoplastic and antiviral compounds in a cell].
Arzumanov AA; Diatkina NB
Bioorg Khim; 1996; 22(10-11):777-94. PubMed ID: 9036839
[No Abstract] [Full Text] [Related]
8. Strategies on the development of small molecule anticancer drugs for targeted therapy.
Lu YH; Gao XQ; Wu M; Zhang-Negrerie D; Gao Q
Mini Rev Med Chem; 2011 Jun; 11(7):611-24. PubMed ID: 21699492
[TBL] [Abstract][Full Text] [Related]
9. Anticancer prodrugs: an overview of major strategies and recent developments.
Arpicco S; Dosio F; Stella B; Cattel L
Curr Top Med Chem; 2011; 11(18):2346-81. PubMed ID: 21671864
[TBL] [Abstract][Full Text] [Related]
10. X-rays Actuate Anticancer Drugs: Opening New Vistas in Prodrug Therapy.
Vaidya SP; Patra M
Chembiochem; 2021 Nov; 22(21):2998-3000. PubMed ID: 34406685
[TBL] [Abstract][Full Text] [Related]
11. Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates.
Thornton PJ; Kadri H; Miccoli A; Mehellou Y
J Med Chem; 2016 Dec; 59(23):10400-10410. PubMed ID: 27559756
[TBL] [Abstract][Full Text] [Related]
12. A novel anticancer theranostic pro-prodrug based on hypoxia and photo sequential control.
Feng W; Gao C; Liu W; Ren H; Wang C; Ge K; Li S; Zhou G; Li H; Wang S; Jia G; Li Z; Zhang J
Chem Commun (Camb); 2016 Aug; 52(60):9434-7. PubMed ID: 27379361
[TBL] [Abstract][Full Text] [Related]
13. Prodrugs for targeted tumor therapies: recent developments in ADEPT, GDEPT and PMT.
Tietze LF; Schmuck K
Curr Pharm Des; 2011; 17(32):3527-47. PubMed ID: 22074425
[TBL] [Abstract][Full Text] [Related]
14. Anticancer platinum (IV) prodrugs with novel modes of activity.
Chin CF; Wong DY; Jothibasu R; Ang WH
Curr Top Med Chem; 2011; 11(21):2602-12. PubMed ID: 22039869
[TBL] [Abstract][Full Text] [Related]
15. Anticancer metallodrugs: where is the next cisplatin?
Hanif M; Hartinger CG
Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in small molecule prodrugs for cancer therapy.
Wang P; Jin X; Cai J; Chen J; Ji M
Anticancer Agents Med Chem; 2014 Mar; 14(3):418-39. PubMed ID: 23869777
[TBL] [Abstract][Full Text] [Related]
17. Drug-glycosidation and drug development.
Kapoor VK; Kaur A
Mini Rev Med Chem; 2013 Apr; 13(4):584-96. PubMed ID: 23244764
[TBL] [Abstract][Full Text] [Related]
18. Medicinal chemistry of nucleoside phosphonate prodrugs for antiviral therapy.
Pertusati F; Serpi M; McGuigan C
Antivir Chem Chemother; 2012 May; 22(5):181-203. PubMed ID: 22182785
[TBL] [Abstract][Full Text] [Related]
19. Prodrugs in photodynamic anticancer therapy.
Musiol R; Serda M; Polanski J
Curr Pharm Des; 2011; 17(32):3548-59. PubMed ID: 22074426
[TBL] [Abstract][Full Text] [Related]
20. Prodrugs in medicinal chemistry and enzyme prodrug therapies.
Walther R; Rautio J; Zelikin AN
Adv Drug Deliv Rev; 2017 Sep; 118():65-77. PubMed ID: 28676386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
